MCM6
Basic information
Region (hg38): 2:135839626-135876443
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Lactose intolerance, adult type; Lactase persistence | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Gastrointestinal | 7543318; 9481112; 11788828; 12915462; 15114531; 16041375; 15928901; 16019716; 17120047; 17159977; 18179885 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MCM6 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 41 | 47 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 3 | |||||
Total | 0 | 0 | 42 | 10 | 6 |
Variants in MCM6
This is a list of pathogenic ClinVar variants found in the MCM6 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-135840873-A-G | not specified • Lactase persistence | Benign/Likely benign (-) | ||
2-135840878-T-C | not specified | Uncertain significance (Jun 28, 2023) | ||
2-135840947-T-C | not specified | Uncertain significance (Mar 25, 2024) | ||
2-135844550-G-A | not specified | Uncertain significance (Feb 15, 2023) | ||
2-135844558-C-T | not specified | Uncertain significance (Oct 25, 2023) | ||
2-135844562-G-A | not specified | Uncertain significance (Oct 25, 2023) | ||
2-135844618-T-C | not specified | Uncertain significance (Feb 10, 2022) | ||
2-135844626-G-A | Benign (Dec 31, 2019) | |||
2-135844679-C-T | not specified | Uncertain significance (Apr 06, 2023) | ||
2-135846225-GGT-G | MCM6-related disorder | Likely benign (Mar 14, 2019) | ||
2-135846246-C-T | not specified | Likely benign (Feb 15, 2023) | ||
2-135846356-T-C | not specified | Uncertain significance (Mar 30, 2024) | ||
2-135848085-A-C | not specified | Uncertain significance (Feb 05, 2024) | ||
2-135848085-A-G | not specified | Uncertain significance (Dec 15, 2023) | ||
2-135848112-T-C | not specified | Uncertain significance (Sep 07, 2022) | ||
2-135848134-G-A | not specified | Uncertain significance (Oct 12, 2022) | ||
2-135851073-G-C | Lactase persistence | association (Nov 20, 2018) | ||
2-135851076-G-A | Lactase persistence | association (Jan 26, 2021) | ||
2-135851079-A-G | Lactase persistence | Uncertain significance (-) | ||
2-135851081-A-C | Lactase persistence | association (Nov 20, 2018) | ||
2-135851176-C-G | Lactase persistence | association (Jun 16, 2015) | ||
2-135851421-C-T | not specified | Uncertain significance (Feb 28, 2024) | ||
2-135851464-G-A | Nonpersistence of intestinal lactase | Uncertain significance (Feb 08, 2021) | ||
2-135851521-G-A | Nonpersistence of intestinal lactase | Uncertain significance (Jan 11, 2024) | ||
2-135852842-T-C | not specified | Uncertain significance (Oct 25, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MCM6 | protein_coding | protein_coding | ENST00000264156 | 17 | 36801 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.978 | 0.0217 | 125733 | 0 | 14 | 125747 | 0.0000557 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.07 | 390 | 454 | 0.859 | 0.0000245 | 5387 |
Missense in Polyphen | 111 | 171.04 | 0.64898 | 1991 | ||
Synonymous | 0.764 | 147 | 159 | 0.923 | 0.00000817 | 1572 |
Loss of Function | 5.05 | 7 | 42.6 | 0.164 | 0.00000247 | 504 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000181 | 0.000181 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.0000441 | 0.0000439 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as component of the MCM2-7 complex (MCM complex) which is the putative replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity. {ECO:0000269|PubMed:9305914}.;
- Pathway
- Cell cycle - Homo sapiens (human);DNA replication - Homo sapiens (human);Cell Cycle;Retinoblastoma (RB) in Cancer;G1 to S cell cycle control;DNA Replication;cdk regulation of dna replication;Activation of ATR in response to replication stress;G2/M Checkpoints;Cell Cycle Checkpoints;Activation of the pre-replicative complex;Unwinding of DNA;Mitotic G1-G1/S phases;Orc1 removal from chromatin;DNA Replication;Switching of origins to a post-replicative state;DNA strand elongation;Synthesis of DNA;S Phase;G1/S Transition;Assembly of the pre-replicative complex;DNA Replication Pre-Initiation;M/G1 Transition;Cell Cycle;Cell Cycle, Mitotic
(Consensus)
Recessive Scores
- pRec
- 0.206
Intolerance Scores
- loftool
- 0.480
- rvis_EVS
- -0.57
- rvis_percentile_EVS
- 18.9
Haploinsufficiency Scores
- pHI
- 0.981
- hipred
- Y
- hipred_score
- 0.831
- ghis
- 0.697
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.546
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mcm6
- Phenotype
- cellular phenotype; growth/size/body region phenotype; neoplasm; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- G1/S transition of mitotic cell cycle;DNA replication;DNA unwinding involved in DNA replication;DNA replication initiation
- Cellular component
- nuclear chromosome, telomeric region;nucleus;nucleoplasm;MCM complex
- Molecular function
- single-stranded DNA binding;ATP-dependent DNA helicase activity;protein binding;ATP binding;identical protein binding